Microscopic drug particles target stomach cancer in early trial
NCT ID NCT05159050
First seen Feb 28, 2026 · Last updated May 24, 2026 · Updated 11 times
Summary
This early-phase trial tested tiny particles loaded with chemotherapy (paclitaxel) for people with cancer spread in the abdomen who had no other treatment options. The goal was to check safety and find the best dose. Only 4 people took part before the study was stopped.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for PERITONEAL CARCINOMATOSIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University of Iowa Hospitals & Clinics
Iowa City, Iowa, 52242, United States
Conditions
Explore the condition pages connected to this study.